{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:46:28Z","timestamp":1761324388349,"version":"3.37.3"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"BRIF","award":["BB-0033-00041"],"award-info":[{"award-number":["BB-0033-00041"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The signal transducer and activator of transcription 6 (STAT6) is implicated in the pathogenesis of some lymphomas including primary central nervous system lymphomas (PCNSLs). The aim of this study was to investigate STAT6 expression and clinicopathologic features in 25 PCNSLs using immunohistochemistry with 2 different anti-STAT6 antibodies. One (YE361) recognizes the C-terminus domain of the STAT6 protein and the other (Y641) recognizes the phosphorylated form of the protein. The phosphorylated STAT6 form was not expressed in any of the cases studied whereas the YE361 STAT6 showed only cytoplasmic expression in 14 (56%) cases. This expression did not correlate with age, prognostic score, multiplicity, invasion of deep structures, response to treatment, disease recurrence, overall survival, or BCL6, BCL2, PD-L1, and CD8 expression. A STAT6 expression score showed a trend for correlating with clinical performance status. It also showed a positive correlation with MYC expression. Thus, the phosphorylated form of STAT6 was not found in the current series, while the YE361 STAT6 showed only cytoplasmic expression and was associated with expression of MYC.<\/jats:p>","DOI":"10.1093\/jnen\/nlab080","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T19:04:02Z","timestamp":1628881442000},"page":"830-834","source":"Crossref","is-referenced-by-count":4,"title":["Expression of STAT6 and Phosphorylated STAT6 in Primary Central Nervous System Lymphomas"],"prefix":"10.1093","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0864-935X","authenticated-orcid":false,"given":"Georgia","family":"Karpathiou","sequence":"first","affiliation":[{"name":"Pathology Department, University Hospital of Saint-Etienne , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise","family":"Ferrand","sequence":"additional","affiliation":[{"name":"Pathology Department, University Hospital of Saint-Etienne , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Camy","sequence":"additional","affiliation":[{"name":"Pathology Department, University Hospital of Saint-Etienne , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia-Maria","family":"Babiuc","sequence":"additional","affiliation":[{"name":"Hematology and Cell Therapy Department, Lucien Neuwirth Cancer Institute , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Papoudou-Bai","sequence":"additional","affiliation":[{"name":"Pathology Department, University Hospital of Ioannina , Ioannina, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Marc","family":"Dumollard","sequence":"additional","affiliation":[{"name":"Pathology Department, University Hospital of Saint-Etienne , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"Cornillon","sequence":"additional","affiliation":[{"name":"Hematology and Cell Therapy Department, Lucien Neuwirth Cancer Institute , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Peoc\u2019h","sequence":"additional","affiliation":[{"name":"Pathology Department, University Hospital of Saint-Etienne , France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,8,13]]},"reference":[{"key":"2024032523414228800_nlab080-B1","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.4155\/fmc-2020-0224","article-title":"The roles of post-translational modifications and coactivators of STAT6 signaling in tumor growth and progression","volume":"12","author":"Huang","year":"2020","journal-title":"Future Med Chem"},{"key":"2024032523414228800_nlab080-B2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12026-011-8205-2","article-title":"Transcriptional regulation by STAT6","volume":"50","author":"Goenka","year":"2011","journal-title":"Immunol Res"},{"key":"2024032523414228800_nlab080-B3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cytogfr.2006.01.004","article-title":"Signaling mechanisms, interaction partners, and target genes of STAT6","volume":"17","author":"Hebenstreit","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"2024032523414228800_nlab080-B4","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1182\/blood-2007-03-082511","article-title":"Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6","volume":"110","author":"Mottok","year":"2007","journal-title":"Blood"},{"key":"2024032523414228800_nlab080-B5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/bjh.12997","article-title":"Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma - A matched pair analysis from the German Hodgkin Study Group (GHSG)","volume":"167","author":"Hartmann","year":"2014","journal-title":"Br J Haematol"},{"key":"2024032523414228800_nlab080-B6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.pathol.4.110807.092209","article-title":"Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma","volume":"4","author":"Schmitz","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"2024032523414228800_nlab080-B7","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1182\/blood.V99.2.618","article-title":"Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"key":"2024032523414228800_nlab080-B8","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41379-019-0428-0","article-title":"Diagnostic utility of STAT6YE361 expression in classical Hodgkin lymphoma and related entities","volume":"33","author":"Van Slambrouck","year":"2020","journal-title":"Mod Pathol"},{"key":"2024032523414228800_nlab080-B9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1182\/blood-2003-10-3545","article-title":"Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma","volume":"104","author":"Guiter","year":"2004","journal-title":"Blood"},{"key":"2024032523414228800_nlab080-B10","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1038\/leu.2008.85","article-title":"STAT6 activity is regulated by SOCS-1 and modulates BCL-XL expression in primary mediastinal B-Cell lymphoma","volume":"22","author":"Ritz","year":"2008","journal-title":"Leukemia"},{"key":"2024032523414228800_nlab080-B11","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/modpathol.2016.51","article-title":"Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36\/TNFRSF14 abnormalities, and STAT6 mutations","volume":"29","author":"Siddiqi","year":"2016","journal-title":"Mod Pathol"},{"key":"2024032523414228800_nlab080-B12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of Follicular Lymphoma Transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep"},{"key":"2024032523414228800_nlab080-B13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"key":"2024032523414228800_nlab080-B14","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood-2014-06-582650","article-title":"Activating STAT6 mutations in follicular lymphoma","volume":"125","author":"Yildiz","year":"2015","journal-title":"Blood"},{"key":"2024032523414228800_nlab080-B15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.humpath.2020.09.014","article-title":"The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma","volume":"106","author":"Barasch","year":"2020","journal-title":"Hum Pathol"},{"key":"2024032523414228800_nlab080-B16","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1182\/blood-2014-07-590398","article-title":"Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation","volume":"125","author":"Geskin","year":"2015","journal-title":"Blood"},{"key":"2024032523414228800_nlab080-B17","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Kluin","year":"2017","edition":"4th ed"},{"key":"2024032523414228800_nlab080-B18","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2005-03-0897","article-title":"Gene expression and angiotropism in primary CNS lymphoma","volume":"107","author":"Rubenstein","year":"2006","journal-title":"Blood"},{"key":"2024032523414228800_nlab080-B19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/hon.2679","article-title":"STAT6 activation correlates with cerebrospinal fluid IL-4 and IL-10 and poor prognosis in primary central nervous system lymphoma","volume":"38","author":"Mondello","year":"2020","journal-title":"Hematol Oncol"},{"key":"2024032523414228800_nlab080-B20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11060-008-9736-9","article-title":"Long-term survival in primary CNS lymphoma treated by high-dose methotrexate monochemotherapy: Role of STAT6 activation as prognostic determinant","volume":"92","author":"Yang","year":"2009","journal-title":"J Neurooncol"},{"key":"2024032523414228800_nlab080-B21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/crj.12982","article-title":"Pleura revisited: From histology and pathophysiology to pathology and molecular biology","volume":"13","author":"Karpathiou","year":"2019","journal-title":"Clin Respir J"},{"key":"2024032523414228800_nlab080-B22","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1200\/JCO.2006.08.2941","article-title":"Primary central nervous system lymphoma: The Memorial Sloan-Kettering Cancer Center prognostic model","volume":"24","author":"Abrey","year":"2006","journal-title":"J Clin Oncol"},{"key":"2024032523414228800_nlab080-B23","doi-asserted-by":"crossref","first-page":"e00928","DOI":"10.1002\/brb3.928","article-title":"Evaluation of Memorial Sloan-Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict Overall Survival in intracranial Primary CNS lymphoma","volume":"8","author":"Jahr","year":"2018","journal-title":"Brain Behav"},{"key":"2024032523414228800_nlab080-B24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/hon.2727","article-title":"Immunohistochemistry for c-myc and bcl-2 overexpression improves risk stratification in primary central nervous system lymphoma","volume":"38","author":"Hatzl","year":"2020","journal-title":"Hematol Oncol"},{"key":"2024032523414228800_nlab080-B25","doi-asserted-by":"crossref","first-page":"e000597","DOI":"10.1136\/jitc-2020-000597","article-title":"Brain metastasis PD-L1 and CD8 expression is dependent on primary tumor type and its PD-L1 and CD8 status","volume":"8","author":"Camy","year":"2020","journal-title":"J Immunother Cancer"},{"key":"2024032523414228800_nlab080-B26","doi-asserted-by":"crossref","first-page":"e1626653","DOI":"10.1080\/2162402X.2019.1626653","article-title":"High tumoral PD-L1 expression and low PD-1 + or CD8 + tumor-infiltrating lymphocytes are predictive of a poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system","volume":"8","author":"Kim","year":"2019","journal-title":"Oncoimmunology"},{"key":"2024032523414228800_nlab080-B27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12885-016-2397-8","article-title":"MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system","volume":"16","author":"Kim","year":"2016","journal-title":"BMC Cancer"},{"key":"2024032523414228800_nlab080-B28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1182\/blood-2011-02-339911","article-title":"Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology","volume":"119","author":"Pello","year":"2012","journal-title":"Blood"},{"key":"2024032523414228800_nlab080-B29","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1158\/1078-0432.CCR-08-2054","article-title":"Pathologic correlates of primary central nervous system lymphoma defined in an orthotopic xenograft model","volume":"15","author":"Kadoch","year":"2009","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Neuropathology &amp; Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/80\/9\/830\/40448993\/nlab080.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/80\/9\/830\/40448993\/nlab080.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:12:20Z","timestamp":1711411940000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnen\/article\/80\/9\/830\/6350867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,13]]},"references-count":29,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,8,13]]},"published-print":{"date-parts":[[2021,9,27]]}},"URL":"https:\/\/doi.org\/10.1093\/jnen\/nlab080","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"type":"print","value":"0022-3069"},{"type":"electronic","value":"1554-6578"}],"subject":[],"published-other":{"date-parts":[[2021,9,1]]},"published":{"date-parts":[[2021,8,13]]}}}